Navigation Links
NASA Nanosatellite to Study Antifungal Drug Effectiveness in Space
Date:4/28/2009

MOFFETT FIELD, Calif., April 28 /PRNewswire-USNewswire/ -- NASA is preparing to fly a small satellite about the size of a loaf of bread that could help scientists better understand how effectively drugs work in space. The nanosatellite, known as PharmaSat, is a secondary payload aboard a U.S. Air Force four-stage Minotaur 1 rocket planned for launch the evening of May 5.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081007/38461LOGO)

PharmaSat weighs approximately 10 pounds. It contains a controlled environment micro-laboratory packed with sensors and optical systems that can detect the growth, density and health of yeast cells and transmit that data to scientists for analysis on Earth. PharmaSat also will monitor the levels of pressure, temperature and acceleration the yeast and the satellite experience while circling Earth at 17,000 miles per hour. Scientists will study how the yeast responds during and after an antifungal treatment is administered at three distinct dosage levels to learn more about drug action in space, the satellite's primary goal.

The Minotaur 1 rocket is on the launch pad at NASA's Wallops Flight Facility and the Mid-Atlantic Regional Spaceport located at Wallops Island, Va. The Wallops range is conducting final checkouts. The U.S. Air Force has announced that the rocket could launch at any time during a three-hour launch window beginning at 8 p.m. EDT May 5.

"Secondary payload nanosatellites expand the number of opportunities available to conduct research in microgravity by providing an alternative to the International Space Station or space shuttle conducted investigations," said Elwood Agasid, PharmaSat project manager at NASA's Ames Research Center in Moffett Field, Calif. "The PharmaSat spacecraft builds upon the GeneSat-1 legacy with enhanced monitoring and measurement capabilities, which will enable more extensive scientific investigation."

After PharmaSat separates from the Minotaur 1 rocket and successfully enters low Earth orbit at approximately 285 miles above Earth, it will activate and begin transmitting radio signals to two ground control stations. The primary ground station at SRI International in Menlo Park, Calif., will transmit mission data from the satellite to the spacecraft operators in the mission control center at NASA's Ames Research Center. A secondary station is located at Santa Clara University in Santa Clara, Calif.

When NASA spaceflight engineers make contact with PharmaSat, which could happen as soon as one hour after launch, the satellite will receive a command to initiate its experiment, which will last 96 hours. Once the experiment begins, PharmaSat will relay data in near real-time to mission managers, engineers and project scientists for further analysis. The nanosatellite could transmit data for as long as six months.

"PharmaSat is an important experiment that will yield new information about the susceptibility of microbes to antibiotics in the space environment," said David Niesel, PharmaSat's co-investigator from the University of Texas Medical Branch Department of Pathology and Microbiology and Immunology in Galveston. "It also will prove that biological experiments can be conducted on sophisticated autonomous nanosatellites."

As with NASA's previous small satellite missions, such as the GeneSat-1, which launched in 2006 and continues to transmit a beacon to Earth, Santa Clara University invites amateur radio operators around the world to tune in to the satellite's broadcast.

For more information and instructions about how to contact PharmaSat, visit:

http://www.nasa.gov/mission_pages/smallsats/pharmasat.html

To view the launch via webcast, visit:

http://sites.wff.nasa.gov/webcast

For the more information about PharmaSat and other small satellite missions, visit:

http://www.nasa.gov/mission_pages/smallsats


'/>"/>
SOURCE NASA
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/25/2016)... ... ... Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and Mental ... exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took place ... BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive an ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Those who ... with these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, ... Marne, Michigan, has released tools for healthy coping following a traumatic event. , Trauma ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 , , , WHEN: ... 2016 , , , , LOCATION: , , , Online, ... , , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global ... Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager ... pharmaceutical industry is witnessing an exceptional era. Several new demand spaces, ...
(Date:6/23/2016)... , June 23, 2016 Revolutionary ... Oticon , industry leaders in advanced audiology ... of Oticon Opn ™, the world,s first internet ... possibilities for IoT devices.      (Photo: ... introduces a number of ,world firsts,: , ...
(Date:6/23/2016)... Research and Markets has announced the addition ... States, China, Japan, Brazil, United Kingdom, Germany, France, Italy, ... Surgical Procedure Volumes: Global ... surgical procedure volume data in a geographic context. The ... of growth drivers and inhibitors, including world population growth, ...
Breaking Medicine Technology: